Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01523652
Recruitment Status : Completed
First Posted : February 1, 2012
Last Update Posted : February 1, 2012
University of Turin, Italy
Information provided by (Responsible Party):
Paolo Zola, Azienda Ospedaliera San Giovanni Battista

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : November 2008